Boz Er, A. B. 2024. Investigation of ITGB3 Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer. BIOLOGY , vol.14, no.1 , 1-16.

Boz Er, A. B., (2024). Investigation of ITGB3 Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer. BIOLOGY , vol.14, no.1, 1-16.

Boz Er, ASİYE. "Investigation of ITGB3 Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer," BIOLOGY , vol.14, no.1, 1-16, 2024

Boz Er, ASİYE B. . "Investigation of ITGB3 Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer." BIOLOGY , vol.14, no.1, pp.1-16, 2024

Boz Er, A. B. (2024) . "Investigation of ITGB3 Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer." BIOLOGY , vol.14, no.1, pp.1-16.

@article{article, author={ASİYE BÜŞRA BOZ ER}, title={Investigation of ITGB3 Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer}, journal={BIOLOGY}, year=2024, pages={1-16} }